• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR ABSOLUTE PRO .035 SELF EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR ABSOLUTE PRO .035 SELF EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM Back to Search Results
Catalog Number 1011915-080
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Stenosis (2263)
Event Date 01/30/2024
Event Type  Injury  
Event Description
Patient id: (b)(6).It was reported that on (b)(6) 2022 the 6.0x8 mm absolute pro stent was implanted in the right distal superficial femoral artery.On (b)(6) 2024 the patient had restenosis in the stented segment, which the physician has deemed as related to non-compliance with the prescribed dual antiplatelet therapy (dapt) of aspirin and clopidogrel.This led to critical ischemia in the extremity.The patient was re-admitted to the hospital and the restenosis was successfully treated with atherectomy and implantation of a stent graft.Although the physician has deemed the restenosis to be related to the non-compliance with dapt, this will be conservatively reported for restenosis of the absolute pro stent.No additional information was provided.
 
Manufacturer Narrative
The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effects of restenosis of stented segment is listed in the absolute pro.035 peripheral self-expanding stent system instructions for use as an adverse events that may be associated with the use of a stent in peripheral arteries and / or biliary tree.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.The treatments appears to be related to the operational context of the procedure.Additionally, per the physician, the reported stenosis appears to be unrelated to the device or the procedure as the patient failed to regularly take the prescribed dual antiplatelet medication.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ABSOLUTE PRO .035 SELF EXPANDING STENT SYSTEM
Type of Device
SELF EXPANDING PERIPHERAL STENT SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key18978520
MDR Text Key338597300
Report Number2024168-2024-03653
Device Sequence Number1
Product Code FGE
UDI-Device Identifier08717648114748
UDI-Public(01)08717648114748(17)251031(10)2110261
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K072708
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 03/26/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number1011915-080
Device Lot Number2110261
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/07/2024
Initial Date FDA Received03/26/2024
Was Device Evaluated by Manufacturer? No
Date Device Manufactured11/02/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age90 YR
Patient SexFemale
Patient Weight60 KG
-
-